【レポートの概要（一部）】
1. Report Overview
1.1 East Asian Pharmaceutical Market Overview
1.2 East Asian Pharmaceutical Market Report Segmentation
1.3 Why You Should Read This Report?
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
1.11 Exchange Rates
2. Introduction to the East Asian Pharmaceutical Market
2.1 National Market Definitions
2.1.1 Japan
2.1.2 Taiwan
2.1.3 Korea
2.2 Other Pharmaceutical Market Definitions
2.2.1 Originator Drugs
2.2.2 Generic Drugs (Generics)
2.2.3 OTC (Over-The-Counter)
2.2.4 Biosimilars
2.3 Introduction to the Global Pharmaceutical Market: A Brief Overview
2.4 Pharmaceutical Approval Regulations
2.4.1 Japan
2.4.2 Taiwan
2.4.3 Korea
2.5 The East Asian Pharmaceutical Market Forecast, 2016-2026
3. The Japanese Pharmaceutical Market
3.1 The Japanese Healthcare System
3.1.1 Costing and Healthcare Delivery
3.1.2 Increasing Generic Penetration: A Matter of Government Policy
3.1.3 Health Technology Assessments
3.2 The Japanese Pharmaceutical Market 2014 and 2015
3.2.1 The Japanese Pharmaceutical Market Forecast, 2016-2026
3.3 The Japanese Pharmaceutical Market 2016-2026: Submarket Shares
3.4 The Japanese Generic Drugs Market 2014
3.4.1 Public Perception Of Generics In Japan
3.4.2 The Japanese Generic Drugs Market Forecast, 2016-2026
3.5 The Japanese Originator Drugs Market 2014
3.5.1 The Japanese Originator Drugs Market Forecast, 2016-2026
3.6 The Japanese OTC Drugs Market 2014 and 2015
3.6.1 The Japanese OTC Drugs Market Forecast, 2016-2026
3.7 The Japanese Biosimilar Drugs Market 2014 and 2015
3.7.1 The Japanese Biosimilar Drugs Market Forecast, 2016-2026
4. Qualitative Analysis of the Japanese Pharmaceutical Market
4.1 SWOT Analysis of The Japanese Pharmaceutical Market, 2016-2026
4.1.1 Strengths
4.1.1.1 Affinity for Branded Products Helping Maintain Revenues
4.1.1.2 High Utilisation of Healthcare Facilities
4.1.1.3 Ageing Population Driving Demand
4.1.2 Weaknesses
4.1.2.1 Reduced Profit Margins Due to Government Pricing
4.1.2.2 Increasing Penetration of Generics Eroding Off-Patent Originator Revenues
4.1.2.3 Restrictions of the OTC Market and Low Consumer Desire
4.1.3 Opportunities
4.1.3.1 Ageing Population Resulting in Increased Demand For High-End Pharmaceuticals
4.1.3.2 New Regulation Allowing for Expansion of the Regenerative Medicine Sector – Sakigake Reforms
4.1.3.3 Increased Trade Opportunities via the Trans-Pacific Partnership (TPP)
4.1.4 Threats
4.1.4.1 Possible Funding Issues Due to Demographics
4.1.4.2 Expanded Use of Biosimilars May Erode Pharmaceutical Market Revenues
4.2 Porter’s Five Forces Analysis of the Japanese Pharmaceutical Market
4.2.1 Rivalry Among Competitors [Medium]
4.2.2 Threat of New Entrants [Medium]
4.2.3 Power of Buyers [Medium]
4.2.4 Power of Suppliers [Medium]
4.2.5 Threat of Substitutes [Medium]
4.3 Leading Japanese Domestic Pharmaceutical Companies
4.3.1 Takeda
4.3.1.1 Litigation Regarding ACTOS in the US
4.3.2 Astellas Pharma
4.3.3 Otsuka Pharmaceuticals
4.3.4 Daiichi Sankyo
4.3.5 Eisai Co.
5. The Taiwanese Pharmaceutical Market
5.1 The Taiwanese Healthcare System
5.1.1 Costing and Healthcare Delivery
5.1.2 Health Technology Assessments
5.2 The Taiwanese Pharmaceutical Market 2014 and 2015
5.2.1 The Taiwanese Pharmaceutical Market Forecast, 2016-2026
5.3 The Taiwanese Pharmaceutical Market 2016-2026: Submarket Shares
5.4 The Taiwanese Generic Drugs Market 2014 and 2015
5.4.1 The Taiwanese Generic Drugs Market Forecast, 2016-2026
5.5 The Taiwanese Originator Drugs Market 2014 and 2015
5.5.1 The Taiwanese Originator Drugs Market Forecast, 2016-2026
5.6 The Taiwanese OTC Drugs Market 2014 and 2015
5.6.1 The Taiwanese OTC Drugs Market Forecast, 2016-2026
5.7 The Taiwanese Biosimilar Drugs Market 2014 and 2015
5.7.1 The Taiwanese Biosimilar Drugs Market Forecast, 2016-2026
6. Qualitative Analysis of the Taiwanese Pharmaceutical Market
6.1 SWOT Analysis of The Japanese Pharmaceutical Market, 2016-2026
6.1.1 Strengths
6.1.1.1 Stable Levels of NHI Funding
6.1.1.2 High Trust and Utilisation of Healthcare Facilities
6.1.1.3 Increasingly Aged Population
6.1.2 Weaknesses
6.1.2.1 Strong Presence of Traditional Medicines
6.1.2.2 Political Isolation and Lack of Bilateral Trade Deals
6.1.3 Opportunities
6.1.3.1 Ageing Population and Associated Pharmaceutical Demand Set to Increase
6.1.3.2 Newly Elected Government Promises Support for Pharmaceutical and Biotechnology Industries
6.1.3.3 The Promotion of Taiwan as a Destination for Medical Tourism
6.1.4 Threats
6.1.4.1 The Influence of China on Taiwanese International Relations
6.1.4.2 Rapid Growth of Pharmaceutical Markets in Rival Asian Countries
6.2 Porter’s Five Forces Analysis of the Taiwanese Pharmaceutical Market
6.2.1 Rivalry Among Competitors [Medium]
6.2.2 Threat of New Entrants [Low]
6.2.3 Power of Buyers [High]
6.2.4 Power of Suppliers [Low]
6.2.5 Threat of Substitutes [High]
6.3 Leading Taiwanese Pharmaceutical Companies
6.3.1 Standard Chem and Pharma Co. (SCP)
6.3.2 Chunghwa Chemical and Pharmaceutical Co.
6.3.3 Yung Shin Pharmaceutical Industry
6.3.4 TWi Biotechnology
6.3.5 OBI Pharmaceutical
7. The Korean Pharmaceutical Market
7.1 The Korean Healthcare System
7.1.1 Costing and Healthcare Delivery
7.2 The Korean Pharmaceutical Market 2014 and 2015
7.2.1 The Korean Pharmaceutical Market Forecast, 2016-2026
7.3 The Korean Pharmaceutical Market 2016-2026: Submarket Shares
7.4 The Korean Generic Drugs Market 2014 and 2015
7.4.1 Pharmaceutical Price Controls and Measures Being Implemented In South Korea
7.4.2 KORUS FTA: The Free Trade Agreement Between South Korea And The US
7.4.3 The Free Trade Agreement between Korea And The European Union
7.4.4 The Korean Generic Drugs Market Forecast, 2016-2026
7.5 The Korean Originator Drugs Market 2014 and 2015
7.5.1 The Korean Originator Drugs Market Forecast, 2016-2026
7.6 The Korean OTC Drugs Market 2014 and 2015
7.6.1 The Korean OTC Drugs Market Forecast, 2016-2026
7.7 The Korean Biosimilar Drugs Market 2014 and 2015
7.7.1 The Korean Biosimilar Drugs Market Forecast, 2016-2026
8. Qualitative Analysis of the Taiwanese Pharmaceutical Market
8.1 SWOT Analysis of The Japanese Pharmaceutical Market, 2016-2026
8.1.1 Strengths
8.1.1.1 Increasing Strength of Domestic Companies
8.1.1.2 Most Rapidly Ageing Population in the World
8.1.1.3 High Rate of OTC Use Among Population
8.1.2 Weaknesses
8.1.2.1 Funding for Healthcare Becoming Stretched and Pharmaceutical Pricing Pressure
8.1.2.2 Export Prices Based on Domestic Reimbursement
8.1.3 Opportunities
8.1.3.1 Ageing Population Will Result in Increased Expenditure
8.1.3.2 Increasing Level of International Sales for Domestic Companies
8.1.3.3 Korea has Registered Interest in Joining the TPP
8.1.4 Threats
8.1.4.1 Korea is Highly Reliant on Other Countries for its Economic Growth
8.1.4.2 Continued Pricing Pressure
8.2 Porter’s Five Forces Analysis of the Korean Pharmaceutical Market
8.2.1 Rivalry Among Competitors [Medium]
8.2.2 Threat of New Entrants [Medium]
8.2.3 Power of Buyers [High]
8.2.4 Power of Suppliers [Low]
8.2.5 Threat of Substitutes [High]
8.3 Leading Korean Pharmaceutical Companies
8.3.1 Daewoong Pharmaceutical Co.
8.3.2 Samsung Bioepis
8.3.3 Celltrion
9. Interviews
9.1 Interview with Sawai Pharmaceuticals, Tokyo, Japan
9.1.1 State of the Pharmaceutical Market in Japan
9.1.2 Current Challenges Facing the Market
9.1.3 Area with Highest Potential for Growth
9.1.4 Effect of Government Policy
9.1.5 Effect of the TPP
9.1.6 Opinions on the Taiwanese and Korean Pharmaceutical Markets
10. Conclusions
10.1 The East Asian Pharmaceutical Market
10.1.1 Ageing Population and Increased Healthcare Spending Pressure
10.1.2 Slowing Economic Growth
10.2 The Japanese Pharmaceutical Market
10.3 The Taiwanese Pharmaceutical Market
10.4 The Korean Pharmaceutical Market
【レポート販売概要】
■ タイトル：東アジアの製薬市場：日本、台湾、韓国■ 英文：East Asian Pharmaceutical Market 2016-2026 : Prospects for Growth Among Drug Classes in Japan, Taiwan and Korea
■ 発行日：2016年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN6041531
■ 調査対象地域：アジア
- Mitsui O.S.K. Lines, Ltd.：石油・ガスバリューチェーン分析レポート2013Mitsui O.S.K. Lines, Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Mitsui O.S.K. Lines, Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Mitsui O.S.K. Lines, Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. …
- Continental Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- クラウドERPの世界市場予測（～2021）：構成要素別（ソリューション、サービス）、機能別、導入形態別、企業規模別、産業別、地域別The cloud Enterprise Resource Planning (ERP) market size is expected to grow from USD 18.52 Billion in 2016 to USD 29.84 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 10.0% during the forecast period. The major growth drivers of the cloud ERP market include, rising adoption of cloud infrastructure and mobile applications, coupled with surge in demand from Small & Medium Enterprises ( …
- 業務用食品陳列棚の世界市場About Commercial Food Display CabinetFood display cabinets refer to food service equipment used for the storing and display of food items. They are used to keep food items at optimal temperatures. Technavio’s analysts forecast the global commercial food display cabinet market to grow at a CAGR of 5.34% during the period 2017-2021. [Covered in this report] The report covers the present scenario and …
- 一次リチウム電池の世界市場2018-2022About this market The rising demand for medical equipment, which includes surgeries and operations demand for batteries that have a long battery life and can be disposed after use. The growing popularity of primary lithium batteries among medical devices manufactures due properties such as small size battery, easy to operate and lightweight. The heart monitoring system requires battery backup solu …
- 世界の自動車産業におけるPLM（製品ライフサイクル管理）市場About PLM in the Automotive Sector Many manufacturing companies need PLM software as it deals with various functional levels of an organization such as product designing, design engineering, and manufacturing. The need for managing a product from the concept to servitization has led to the emergence of PLM software and services. The growing product complexity and increase in product portfolio acro …
- 3Dセンシング技術の世界市場展望2017-20276According to Stratistics MRC, the Global 3D Sensing Technology Market is accounted for $882.10 million in 2017 and is expected to reach $4,982.90 million by 2026 growing at a CAGR of 21.2% during the forecast period. Some of the key factors influencing the market growth include increase in demand of biometric authentication, growing demand for 3d sensors in consumer electronics and increase in num …
- 世界のマクロセル・モバイルバックホール 装置市場動向（2012-2016）TechNavio's analysts forecast the Global Macrocell Mobile Backhaul Equipment market to grow at a CAGR of 6.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in data traffic. The Global Macrocell Mobile Backhaul Equipment market has also been witnessing the growing adoption of IP/Ethernet technology. However, the reduced profits could po …
- モバイルルーターの世界市場2015-2019About Mobile Hotspot Router A mobile hotspot is a very compact wireless router that enables end-users to avail high-speed Internet services without any wires, because devices are connected via 3G or 4G mobile connections. It provides connectivity within a range of 30-33 feet and allows end-users to connect multiple Wi-Fi-enabled devices to a single router, thereby helping reduce the overall cost o …
- 不揮発性メモリの世界市場予測（～2022年）“Non-volatile memory market is projected to grow at a CAGR of 9.96% between 2016 and 2022.”The non-volatile memory market has entered the growth phase and is expected to grow further in the coming years. The market is expected to be worth USD 81.51 billion in 2022, at a CAGR of 9.96% between 2016 and 2022. The drivers for this market are the need for high-speed, low-power consuming, and highly sca …
- ポリアクリル酸の世界市場2015Polyacrylic acid (CAS 9003-1-4) Market Research Report 2015 aims at providing comprehensive data on Polyacrylic acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Polyacrylic acid description, covers its application areas, manufacturing methods, patterns. It captures Polyacrylic acid market trends, pays close attention to Polyacrylic acid manu …
- 無菌包装の世界市場2017-2021About Aseptic Packaging Aseptic packaging is the packaging of products in the aseptic environment in pre-sterilized containers, to prevent the products from contamination and maintain freshness for a long period of time. Aseptic packaging involves flash pasteurization of products to retain their original aroma, texture, and organoleptic characteristics and contains no preservatives or additives. T …
- 侵入検出システム/侵入防止システムのグローバル市場動向(2014-2019)The complete Global Intrusion Detection and Prevention System security market is categorized basically into three segments Network based, Host based and Wireless IDS/IPS solutions. The evolution of the IDS/IPS security solutions was started with the Host based solution when first time Intrusion Detection systems was designed for the military and defense purpose. Later on the other two segments eme …
- 世界の主要な先進運転支援システム(ADAS)企業分析2016ADAS technologies are undeniably one of the fastest growing areas within the automotive industry. Who will be the top players in this dynamic market and what are their prospects? What is their respective revenue and market share by the end of 2016? And what is their future outlook? We break down the most important sub segment of the automotive industry but also the key player’s market shares, reve …
- 医療マリファナの世界市場分析：用途別（慢性疼痛、関節炎、片頭痛、がん）、国別（アメリカ、カナダ、フランス、イタリア、スイス、イスラエル、ベルギー、クロアチア、フィンランド、オランダ、ポルトガル、チェコ共和国、エストニア）、セグメント予測、2013-2025The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025, according to a new report by Grand View Research, Inc. It has been identified that, in 2016, Washington D.C. along with 28 states have legalized marijuana for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania were approved to use the drug in medical applications …
